STOCK TITAN

Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Eli Lilly and Company (NYSE: LLY) has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024. Jacob Van Naarden, executive vice president and president of Lilly Oncology, will engage in a fireside chat at 7:45 a.m. Eastern time.

Investors and interested parties can access a live audio webcast of the presentation through Lilly's Investor website. The webcast will be available in the 'Webcasts & Presentations' section at https://investor.lilly.com/webcasts-and-presentations. For those unable to attend live, a replay of the presentation will be accessible on the same website for approximately 90 days following the event.

Eli Lilly and Company (NYSE: LLY) ha annunciato la propria partecipazione al 22° Annual Global Healthcare Conference di Morgan Stanley che si terrà il 5 settembre 2024. Jacob Van Naarden, vicepresidente esecutivo e presidente di Lilly Oncology, parteciperà a una chiacchierata informale alle 7:45 a.m. ora orientale.

Gli investitori e gli interessati possono accedere a un webcast audio in diretta della presentazione attraverso il sito web per gli investitori di Lilly. Il webcast sarà disponibile nella sezione 'Webcasts & Presentations' su https://investor.lilly.com/webcasts-and-presentations. Per coloro che non possono partecipare dal vivo, un riproduzione della presentazione sarà accessibile sullo stesso sito per circa 90 giorni dopo l'evento.

Eli Lilly and Company (NYSE: LLY) ha anunciado su participación en la 22ª Conferencia Global Anual de Atención Médica de Morgan Stanley que se celebrará el 5 de septiembre de 2024. Jacob Van Naarden, vicepresidente ejecutivo y presidente de Lilly Oncology, participará en una charla informal a las 7:45 a.m. hora del Este.

Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de inversores de Lilly. El webcast estará disponible en la sección 'Webcasts & Presentations' en https://investor.lilly.com/webcasts-and-presentations. Para aquellos que no puedan asistir en vivo, una reproducción de la presentación estará accesible en el mismo sitio durante aproximadamente 90 días después del evento.

엘리 릴리 컴퍼니 (NYSE: LLY)모건 스탠리 제22회 글로벌 헬스케어 콘퍼런스에 참가한다고 발표했습니다. 이는 2024년 9월 5일에 열리며, 제이콥 반 나르덴 Lilly Oncology의 부회장 겸 사장이 동부 표준시 기준 오전 7시 45분에 대화에 참여합니다.

투자자와 관련자는 Lilly 투자자 웹사이트를 통해 프리젠테이션의 실시간 오디오 웹캐스트에 접근할 수 있습니다. 웹캐스트는 https://investor.lilly.com/webcasts-and-presentations의 'Webcasts & Presentations' 섹션에서 확인할 수 있습니다. 실시간 참석이 불가능한 경우, 프리젠테이션의 재생본은 이벤트 후 약 90일 동안 동일한 웹사이트에서 접근할 수 있습니다.

Eli Lilly and Company (NYSE: LLY) a annoncé sa participation à la 22e Conférence annuelle mondiale sur la santé de Morgan Stanley qui se tiendra le 5 septembre 2024. Jacob Van Naarden, vice-président exécutif et président de Lilly Oncology, participera à une discussion informelle à 7h45, heure de l'Est.

Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de la présentation via le site pour investisseurs de Lilly. Le webcast sera disponible dans la section 'Webcasts & Presentations' à l'adresse https://investor.lilly.com/webcasts-and-presentations. Pour ceux qui ne peuvent pas assister en direct, une rediffusion de la présentation sera accessible sur le même site pendant environ 90 jours après l'événement.

Eli Lilly and Company (NYSE: LLY) hat seine Teilnahme an der 22. Jahresglobalen Gesundheitskonferenz von Morgan Stanley am 5. September 2024 angekündigt. Jacob Van Naarden, Executive Vice President und Präsident von Lilly Oncology, wird um 7:45 Uhr Eastern Time an einer Gesprächsrunde teilnehmen.

Investoren und Interessierte können über die Investor-Website von Lilly auf einen Live-Audio-Webcast der Präsentation zugreifen. Der Webcast wird im Abschnitt 'Webcasts & Presentations' unter https://investor.lilly.com/webcasts-and-presentations verfügbar sein. Für diejenigen, die nicht live teilnehmen können, wird eine Wiedergabe der Präsentation im gleichen Website für ungefähr 90 Tage nach der Veranstaltung zugänglich sein.

Positive
  • None.
Negative
  • None.

INDIANAPOLIS, Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden, executive vice president and president, Lilly Oncology, will participate in a fireside chat at 7:45 a.m. Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. F-LLY

Refer to:         Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
                        Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors)

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-morgan-stanley-22nd-annual-global-healthcare-conference-302227835.html

SOURCE Eli Lilly and Company

FAQ

When is Eli Lilly (LLY) participating in the Morgan Stanley Healthcare Conference?

Eli Lilly (LLY) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024.

Who will represent Eli Lilly (LLY) at the Morgan Stanley Healthcare Conference?

Jacob Van Naarden, executive vice president and president of Lilly Oncology, will represent Eli Lilly (LLY) at the conference.

What time is Eli Lilly's (LLY) fireside chat at the Morgan Stanley conference?

Eli Lilly's (LLY) fireside chat is scheduled for 7:45 a.m. Eastern time on September 5, 2024.

How can investors watch Eli Lilly's (LLY) presentation at the Morgan Stanley conference?

Investors can watch a live audio webcast of Eli Lilly's (LLY) presentation on the company's Investor website at https://investor.lilly.com/webcasts-and-presentations.

How long will the replay of Eli Lilly's (LLY) Morgan Stanley conference presentation be available?

The replay of Eli Lilly's (LLY) presentation will be available on the company's Investor website for approximately 90 days after the event.

Eli Lilly & Co.

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Stock Data

877.37B
950.41M
0.15%
83.49%
0.6%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
INDIANAPOLIS